ARA 290 is a synthetic 11–amino acid peptide engineered from a region of erythropoietin. It has been studied in clinical and research settings for its activity at the innate repair receptor (IRR), a receptor complex involving EPOR and the β-common receptor, and its role in tissue-protective signaling pathways independent of erythropoietic mechanisms.